Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial

Benzer Materyaller

• Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.
  Yazar:: Vora, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• UKALL 2003, A Randomised Trial Investigating Treatment Intensification for Children and Young Adults with Minimal Residual Disease Defined High Risk Acute Lymphoblastic Leukaema
  Yazar:: Vora, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.
  Yazar:: Vora, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): A randomised controlled trial
  Yazar:: Vora, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• UKALL 2003, A Randomised Trial Investigating Treatment Reduction for Children and Young Adults with Minimal Residual Disease Defined Low Risk Acute Lymphoblastic Leukaemia
  Yazar:: Vora, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)